| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |